LOGEX International Healthcare Analytics B.V.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
LOGEX International Healthcare Analytics B.V. - overview
Established
2018
Location
Amsterdam, -, Netherlands
Primary Industry
Healthcare IT
About
LOGEX International Healthcare Analytics B. V. , based in the Netherlands, specializes in healthcare analytics, delivering solutions that empower healthcare providers and governmental organizations with actionable insights derived from data. Founded in 2018 and headquartered in Amsterdam, Netherlands, LOGEX International Healthcare Analytics B.
V. focuses on providing advanced analytics solutions to the healthcare sector. The company has engaged in two significant deals, with the most recent occurring on March 1, 2023. Rudolph Haardt is the Founder, while Philipp Jan Flach serves as the CEO.
LOGEX specializes in healthcare analytics, offering solutions including Financial Analytics, Real-World Data platforms, Clinical Registries, and Patient Engagement tools. These services are designed to enhance data-driven decision-making for healthcare providers and governmental organizations, addressing challenges related to affordability, accessibility, and quality of care. LOGEX serves clients in Germany, Switzerland, Sweden, Finland, Norway, the Netherlands, and the United Kingdom, using anonymized data to improve operational efficiency and patient outcomes. LOGEX generates revenue through subscription-based services and partnerships with healthcare organizations, providing continuous access to analytics and support.
Their business model includes tailored partnerships for integrating their solutions into existing systems. Specific pricing structures are not publicly disclosed, but a tiered pricing strategy is likely employed based on the complexity of the solutions offered, including flagship products like Financial Analytics and Real-World Evidence platforms. Following a recent investment from Thoma Bravo on March 1, 2023, with undisclosed financial terms, LOGEX plans to utilize the funds to bolster its growth across Europe and advance innovation in healthcare analytics. The company is focused on expanding into new markets, although specific regions and product launches have not yet been detailed.
Current Investors
Thoma Bravo, Summa Equity
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software, Analytics & Performance Software
Website
www.logex.com/
Verticals
Cloud Computing, HealthTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
LOGEX International Healthcare Analytics B.V. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | LOGEX International Healthcare Analytics B.V. | - | ||||||||
| Buyout | Completed | LOGEX International Healthcare Analytics B.V. | - | ||||||||
| Trade Sale | Completed | IVBAR Institute AB | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.